Please login to the form below

Not currently logged in
Email:
Password:

Eisenmenger syndrome

This page shows the latest Eisenmenger syndrome news and features for those working in and with pharma, biotech and healthcare.

Actelion reports late-stage trial failure as J&J talks continue

Actelion reports late-stage trial failure as J&J talks continue

Actelion has revealed that a late-stage trial of Opsumit in patients with Eisenmenger syndrome failed to meet its objectives, just as it is immersed in takeover talks with Johnson &Johnson ... MAESTRO involved 266 patients with pulmonary artery

Latest news

More from news
Approximately 1 fully matching, plus 0 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Hanover Communications

Healthcare is evolving rapidly. To stand out from the crowd requires a potent combination of rich insight, innovative ideas and...

Latest intelligence

Top 10 ways to leverage the Impetus InSite Platform® to (virtually) launch your brand
The Impetus InSite Platform® can be used to facilitate virtual and hybrid engagement at all stages of the product lifecycle. Here, we share 10 of the most popular ways to...
Employee wellbeing in creative agencies: three tips to get you started
Paul Hutchings, founder of fox&cat, and new friend, Welfy, a workplace wellbeing training firm, discuss the importance of collaboration...
Managing unhelpful pressure in your creative agency: the human approach
Paul Hutchings, founder of fox&cat, answers the questions: what does it mean to be human in 2021? Are we putting ourselves under too much pressure?...